Crystalline forms of MNK inhibitors
The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, incl...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
28.09.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers. |
---|---|
AbstractList | The present invention provides crystalline solids of 6′-((6-aminopyrimidin-4-yl)amino)-8′-methyl-2′H-spiro[cyclohexane-1,3′-imidazo[1,5-a]pyridine]-1′,5′-dione:The crystalline compounds of the present application are inhibitors of Mnk and finds utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers. |
Author | Borer, Bennett C Sprengeler, Paul A Xiang, Alan X Reich, Siegfried H Webber, Stephen E Wilson, Jo Ann Z Ernst, Justin T Sperry, Samuel |
Author_xml | – fullname: Ernst, Justin T – fullname: Reich, Siegfried H – fullname: Webber, Stephen E – fullname: Xiang, Alan X – fullname: Borer, Bennett C – fullname: Sperry, Samuel – fullname: Wilson, Jo Ann Z – fullname: Sprengeler, Paul A |
BookMark | eNrjYmDJy89L5WRQdi6qLC5JzMnJzEtVSMsvyi1WyE9T8PXzVsjMy8hMyizJLyrmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxocGGhobGBuam5k5GxsSoAQCxVygV |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US11130757B2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US11130757B23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 13:02:22 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US11130757B23 |
Notes | Application Number: US201916661507 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210928&DB=EPODOC&CC=US&NR=11130757B2 |
ParticipantIDs | epo_espacenet_US11130757B2 |
PublicationCentury | 2000 |
PublicationDate | 20210928 |
PublicationDateYYYYMMDD | 2021-09-28 |
PublicationDate_xml | – month: 09 year: 2021 text: 20210928 day: 28 |
PublicationDecade | 2020 |
PublicationYear | 2021 |
RelatedCompanies | eFFECTOR Therapeutics Inc |
RelatedCompanies_xml | – name: eFFECTOR Therapeutics Inc |
Score | 3.3538876 |
Snippet | The present invention provides crystalline solids of... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | Crystalline forms of MNK inhibitors |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210928&DB=EPODOC&locale=&CC=US&NR=11130757B2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp6Lzg4rStyJkXZs-FKFpy1DaDbfK3kbTNKw-dGOtiP-9l9I5X_QtJHBJDn73kcvdATwISvKMEmGkUpoqzMgNng0sQwpnwKVtOSRTucNRbI0S83k-nHfgfZsL09QJ_WyKIyKiMsR73cjr9e4Ry2_-VlaPvMCp1VM4c3299Y7Rf3EI1X3PDSZjf8x0xtxkqsevruqojtrR9lBc76EZbSs0BG-eykpZ_1Yp4THsT5BaWZ9AJy97cMi2ndd6cBC1AW8cttirTuGebb7QlFM1tHNNmZqVtpJaFL9oRbkseKHa5pzBXRjM2MjA3RY_V1sk093BBufQRZc_vwBtaKeSZHZmCrRwuDA5TaUjuEVF7nAuySX0_6bT_2_xCo4Um9SPB0KvoVtvPvIbVKs1v2348Q3fzn0K |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkXnV0XpWxGyrh8PRVi7Mt3aDdfK3krTJKw-dGOtiP-9l7I5X_QtJHBJDn73kcvdATwwi_DMIkxLhdBlmJFqNOsammB2lwrTsEkmc4eD0BjG-su8N2_A-zYXpq4T-lkXR0REZYj3qpbXq90jllf_rSwfaY5Tyyc_cjx14x2j_2ITS_X6zmA68Sau6rpOPFPDV0d2VEftaPZRXO-hiW1KNAze-jIrZfVbpfhHsD9FakV1DA1etKHlbjuvteEg2AS8cbjBXnkC9-76C005WUObK9LULJWlUIJwpOTFIqe5bJtzCnf-IHKHGu6W_FwtiWe7g3XPoIkuPz8HpWemgmRmpjO0cCjTqZUKm1HDYtymVJAL6PxNp_Pf4i20hlEwTsbP4egSDiXL5O8HYl1Bs1p_8GtUsRW9qXnzDedef_0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Crystalline+forms+of+MNK+inhibitors&rft.inventor=Ernst%2C+Justin+T&rft.inventor=Reich%2C+Siegfried+H&rft.inventor=Webber%2C+Stephen+E&rft.inventor=Xiang%2C+Alan+X&rft.inventor=Borer%2C+Bennett+C&rft.inventor=Sperry%2C+Samuel&rft.inventor=Wilson%2C+Jo+Ann+Z&rft.inventor=Sprengeler%2C+Paul+A&rft.date=2021-09-28&rft.externalDBID=B2&rft.externalDocID=US11130757B2 |